Cellulite Treatment Market
Cellulite Treatment Market Size, Share & Forecast Analysis, By Procedure Type (Non-invasive, Minimally Invasive, Topical), By Cellulite Type (Soft Cellulite, Hard Cellulite), By End-use (Hospitals, Clinics & Beauty Centers), & Region - Global Market Insights 2022-2032
Analysis of Cellulite Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cellulite Treatment Market Outlook (2022-2032)
The global market for cellulite treatment is likely to be valued at around US$ 1.46 Billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12% from 2022 to 2032. Increasing demand for cosmetic and aesthetic procedures along with the rise in the obese population is anticipated to fuel the industry growth.
According to the WHO data, in 2016, more than 340 million children and adolescents were either overweight or obese and nearly 650 million adults were obese. Such high prevalence is anticipated to fuel industry growth. Furthermore, cellulite affects an individual’s psychological, behavioural, and psychiatric characteristics, which is anticipated to increase the market demand. For instance, according to the study published by Surgical and Cosmetic Dermatology regarding the psychology of patients with cellulite, nearly 50% of the study population reported dissatisfaction regarding their appearance while nearly 78% reported the need to seek treatment.
Report Attributes |
Details |
|---|---|
|
Market Size (2021A) |
US$ 1.30 Billion |
|
Estimated Market Value (2022E) |
US$ 1.46 Billion |
|
Forecasted Market Value (2032F) |
US$ 4.52 Billion |
|
Global Market Growth Rate (2022-2032) |
12% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Revenue Analysis of Cellulite Treatment Market from 2017-2021 Vs Market Projections for 2022 to 2032
The COVID-19 pandemic significantly impacted all markets and businesses around the world, including the aesthetics market. Lockdowns imposed in nearly all countries had a severely negative impact on the global economy. The COVID-19 pandemic also impacted the market for cellulite treatment. In the U.S., around 86,350 cellulite treatment procedures were undertaken in 2020.
As per the report of Plastic Surgery Statistics 2020, there was a 24% decline in cellulite procedures from 2019 to 2020. COVID-19 can be partially attributed to an increased usage of online conferences, social media, and digital technology during the pandemic and post-pandemic period, which often accentuates personal and idealized facial aesthetics. The demand for the online consultation process has increased, and it is integrated into routine treatments to reduce the risk of direct face-to-face contact with the patient.
Health authorities ordered all aesthetic clinics to immediately stop seeing and treating patients, except in emergencies, resulting in office closures and unprecedented revenue decline across the sector. By the end of 2020, aesthetic clinics started witnessing lucrative growth as the demand for cosmetic procedures increased. Many cosmetic surgeons started online consultations during the pandemic as well as post-pandemic landscape via digital applications.
Which are Some Prominent Drivers of the Cellulite Treatment Market?
Advancements in Technology and Introduction of Novel Products will Drive Demand for Cellulite Treatment Services
The introduction of novel products in the market is also anticipated to fuel market growth. For instance, in 2016, Merz Pharma introduced Cellfina, a cellulite appearance enhancing treatment that lasts for at least 3 years. Moreover, nearly 78% of U.S. women can be potentially treated with this system, while more than 93% of the treated patients were satisfied with the treatment results.
Hence, such novel systems are projected to boost market growth. Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to the American Society of Plastic Surgeons, 15.9 million cosmetic minimally-invasive procedures were carried out in 2018, out of which 473,316 were non-invasive fat reduction procedures.
Furthermore, the increasing number of celebrities and social media influencers showcasing their well-toned body shapes on social media platforms has triggered a need for achieving those body standards, especially among women. Such social pressure to achieve the perfect body shape and associated negative body image is anticipated to increase the number of treatment-seeking individuals, thus supporting the market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Challenges Faced by the Cellulite Treatment Market?
High Cost of Treatment to Obstruct the Market Growth Rate
High cost of treatment along with feasible side effects of the treatment, associated with availability of improved treatment alternatives will obstruct the market's growth rate.
What Prospects Define Cellulite Treatment Market Potential on a Regional Basis?
North America holds the largest revenue share of over 35.0% due to the high availability of skilled professionals, advanced techniques, and supportive government initiatives in the region. For instance, according to The International Society of Plastic Surgery 2017 study, nearly 6,800 plastic surgeons were present in the U.S. as compared to 5,500 plastic surgeons in Brazil.
Moreover, the availability and adoption of advanced treatment options, such as laser treatments, are contributing to market growth in this region. In addition, rising consciousness about aesthetic appeal and outward appearance is propelling the growth of the industry in North America.
Asia Pacific is anticipated to witness lucrative growth over the forecast period. This can be attributed to cheaper treatment costs, increasing disposable income, and increasing prevalence of obesity in this region.
Country-wise Analysis
What Will Keep the Momentum High for the U.S. Cellulite Treatment Market?
Increasing Cases of Obesity bolstering demand for Cellulite Treatment
According to the Centers for Disease Control and Prevention, from 1999 –2000 through 2017 –March 2020, US obesity prevalence increased from 30.5% to 41.9%. During the same time, the prevalence of severe obesity increased from 4.7% to 9.2%.
A rise in a shift towards the Non-invasive treatments from surgical procedures has been increased in recent years. For instance, according to the 2018 Plastic Surgery Statistics, 5.8 million reconstructive procedures were recorded worldwide which decreased the past couple years indicating the preference for Non-invasive treatments fueling the market in the region.
Why is India a Prominent Market for cellulite treatment?
Positively Growing Medical Tourism to Push Demand for cellulite treatment
India is one of the fastest-growing economies among the major countries. The majority of the countries in this region are developing nations and are rapidly adopting technologically advanced equipment. Medical tourism is also high in this region, which is anticipated to further propel industry growth. The number of women and men concerned about their aesthetic appeal and outward appearance has also increased drastically in the past few years, thus driving the market in this region.
Category-wise Insights
Which Cellulite Type is expected to push Demand?
Soft Cellulite is anticipated to Attract lucrative growth
The soft cellulite segment held the largest revenue share of over 45.0% in 2021. This can be attributed to the high prevalence of obesity owing to unhealthy diet and lifestyle habits. Soft cellulite is mainly found in areas such as the buttocks, abdomen, thighs, and arms.
Improvement of muscle tone by exercising, steady weight loss, adequate protein intake, and radiofrequency and topical treatments are some preferred treatment options for soft cellulite. Soft cellulite is relatively easier to treat as compared to the other forms and thus, is anticipated to witness lucrative growth over the forecast period.
Hard cellulite is compact in nature and painful when touched. Hard cellulite is present on the outer areas of thighs and hips. Mesotherapy is one of the suggested treatment options for hard cellulite, involving injection of customized combinations of natural extracts, vitamins, and drugs into the mesoderm layer.
How are End-Users Generating High Revenue for Market Players?
Demand from Clinics and Beauty Centers to Positively Impact Market Growth
The clinics and beauty centers segment held the largest revenue share of over 60.0% in 2021. Cellulite formation is a common problem observed in women aged 20 and above. It is considered a cosmetic problem, therefore patients seek various aesthetic centers for its treatment.
Hospitals and beauty clinics both provide patients with effective treatment options. Demand for beauty centers and clinics is increasing owing to rising incidence of cellulite formation along with aesthetic-related conditions. Generally, cases from hospitals are referred to aesthetic clinics and beauty centers, leading to an increase in the demand for such centers.
In addition, some patients prefer home-based remedies such as over-the-counter topical creams available for the treatment of cellulite. The presence of skilled staff and certified professionals at these clinics and beauty spas reduce the risk of complications. Moreover, the opening of various clinics and medical spa centers around the world due to low regulatory requirements for nonsurgical cosmetic procedures is a key growth factor.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Market Competition
Prominent cellulite treatment companies are Merz Pharma; Hologic, Inc. (Cynosure); Syneron Medical; Zimmer Aesthetics; Alma Lasers; Cymedics; Nubway.
The global cellulite treatment market is highly competitive owing to the top global players trying to gain market share through various strategies such as mergers & acquisitions, expansions, collaborations, and partnerships.
- In April 2021, The U.S. Food and Drug Administration (FDA) approved the first injectable treatment for buttock cellulite. The novel injectable enzyme therapy, known as Qwo, is now accessible in medical offices as well
- In 2021, a brand-new cellulite treatment method was launched and quickly gained popularity. This non-invasive cellulite treatment method, known as Resonic, seeks to reduce cellulite in just one hour long session.
Key Segments Profiled in the cellulite treatment Industry Survey
-
By Procedure Type :
- Non-invasive
- Minimally Invasive
- Topical
-
By Cellulite Type :
- Soft Cellulite
- Hard Cellulite
- Edematous Cellulite
-
By End-Use Industry :
- Hospitals
- Clinics & Beauty Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Procedure Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure Type, 2022-2032 5.3.1. Non-invasive 5.3.2. Minimally invasive 5.3.3. Topical 5.4. Y-o-Y Growth Trend Analysis By Procedure Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Procedure Type, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Cellulite Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Cellulite Type, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Cellulite Type, 2022-2032 6.3.1. Soft cellulite 6.3.2. Hard cellulite 6.3.3. Edematous cellulite 6.4. Y-o-Y Growth Trend Analysis By Cellulite Type, 2017-2021 6.5. Absolute $ Opportunity Analysis By Cellulite Type, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End-use , 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use , 2022-2032 7.3.1. Hospitals 7.3.2. Clinics & beauty centres 7.4. Y-o-Y Growth Trend Analysis By End-use , 2017-2021 7.5. Absolute $ Opportunity Analysis By End-use , 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Procedure Type 9.2.3. By Cellulite Type 9.2.4. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Procedure Type 9.3.3. By Cellulite Type 9.3.4. By End-use 9.4. Key Takeaways 10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Procedure Type 10.2.3. By Cellulite Type 10.2.4. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Procedure Type 10.3.3. By Cellulite Type 10.3.4. By End-use 10.4. Key Takeaways 11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Procedure Type 11.2.3. By Cellulite Type 11.2.4. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Procedure Type 11.3.3. By Cellulite Type 11.3.4. By End-use 11.4. Key Takeaways 12. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Procedure Type 12.2.3. By Cellulite Type 12.2.4. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Procedure Type 12.3.3. By Cellulite Type 12.3.4. By End-use 12.4. Key Takeaways 13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Procedure Type 13.2.3. By Cellulite Type 13.2.4. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Procedure Type 13.3.3. By Cellulite Type 13.3.4. By End-use 13.4. Key Takeaways 14. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Procedure Type 14.2.3. By Cellulite Type 14.2.4. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Procedure Type 14.3.3. By Cellulite Type 14.3.4. By End-use 14.4. Key Takeaways 15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Procedure Type 15.2.3. By Cellulite Type 15.2.4. By End-use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Procedure Type 15.3.3. By Cellulite Type 15.3.4. By End-use 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. U.S. 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Procedure Type 16.1.2.2. By Cellulite Type 16.1.2.3. By End-use 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Procedure Type 16.2.2.2. By Cellulite Type 16.2.2.3. By End-use 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Procedure Type 16.3.2.2. By Cellulite Type 16.3.2.3. By End-use 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Procedure Type 16.4.2.2. By Cellulite Type 16.4.2.3. By End-use 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Procedure Type 16.5.2.2. By Cellulite Type 16.5.2.3. By End-use 16.6. U.K. 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Procedure Type 16.6.2.2. By Cellulite Type 16.6.2.3. By End-use 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Procedure Type 16.7.2.2. By Cellulite Type 16.7.2.3. By End-use 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Procedure Type 16.8.2.2. By Cellulite Type 16.8.2.3. By End-use 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Procedure Type 16.9.2.2. By Cellulite Type 16.9.2.3. By End-use 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Procedure Type 16.10.2.2. By Cellulite Type 16.10.2.3. By End-use 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Procedure Type 16.11.2.2. By Cellulite Type 16.11.2.3. By End-use 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Procedure Type 16.12.2.2. By Cellulite Type 16.12.2.3. By End-use 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Procedure Type 16.13.2.2. By Cellulite Type 16.13.2.3. By End-use 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Procedure Type 16.14.2.2. By Cellulite Type 16.14.2.3. By End-use 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Procedure Type 16.15.2.2. By Cellulite Type 16.15.2.3. By End-use 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Procedure Type 16.16.2.2. By Cellulite Type 16.16.2.3. By End-use 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Procedure Type 16.17.2.2. By Cellulite Type 16.17.2.3. By End-use 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Procedure Type 16.18.2.2. By Cellulite Type 16.18.2.3. By End-use 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Procedure Type 16.19.2.2. By Cellulite Type 16.19.2.3. By End-use 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Procedure Type 16.20.2.2. By Cellulite Type 16.20.2.3. By End-use 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Procedure Type 16.21.2.2. By Cellulite Type 16.21.2.3. By End-use 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Procedure Type 17.3.3. By Cellulite Type 17.3.4. By End-use 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Cymedics 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Nubway 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Syneron Medical Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Zimmer Aesthetics 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Alma Lasers 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Merz Pharma 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Hologic, Inc. (Cynosure) 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Inceler Medikal Co. Ltd. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Tanceuticals LLC 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Merz Pharma GmbH & Co. KGaA 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 03: Global Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 04: Global Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 05: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 06: North America Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 07: North America Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 08: North America Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 09: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 15: Europe Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 16: Europe Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 17: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: South Asia Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 19: South Asia Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 20: South Asia Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: East Asia Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 23: East Asia Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 24: East Asia Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 25: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: Oceania Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 27: Oceania Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 28: Oceania Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 29: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 30: MEA Market Value (US$ Mn) Forecast by Procedure Type, 2017-2032
Table 31: MEA Market Value (US$ Mn) Forecast by Cellulite Type, 2017-2032
Table 32: MEA Market Value (US$ Mn) Forecast by End-use , 2017-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 02: Global Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 03: Global Market Value (US$ Mn) by End-use , 2022-2032
Figure 04: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 05: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 06: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 07: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 08: Global Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 09: Global Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 11: Global Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 14: Global Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 17: Global Market Attractiveness by Procedure Type, 2022-2032
Figure 18: Global Market Attractiveness by Cellulite Type, 2022-2032
Figure 19: Global Market Attractiveness by End-use , 2022-2032
Figure 20: Global Market Attractiveness by Region, 2022-2032
Figure 21: North America Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 22: North America Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 23: North America Market Value (US$ Mn) by End-use , 2022-2032
Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 37: North America Market Attractiveness by Procedure Type, 2022-2032
Figure 38: North America Market Attractiveness by Cellulite Type, 2022-2032
Figure 39: North America Market Attractiveness by End-use , 2022-2032
Figure 40: North America Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 42: Latin America Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 43: Latin America Market Value (US$ Mn) by End-use , 2022-2032
Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 54: Latin America Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 57: Latin America Market Attractiveness by Procedure Type, 2022-2032
Figure 58: Latin America Market Attractiveness by Cellulite Type, 2022-2032
Figure 59: Latin America Market Attractiveness by End-use , 2022-2032
Figure 60: Latin America Market Attractiveness by Country, 2022-2032
Figure 61: Europe Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 62: Europe Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 63: Europe Market Value (US$ Mn) by End-use , 2022-2032
Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 71: Europe Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 74: Europe Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 77: Europe Market Attractiveness by Procedure Type, 2022-2032
Figure 78: Europe Market Attractiveness by Cellulite Type, 2022-2032
Figure 79: Europe Market Attractiveness by End-use , 2022-2032
Figure 80: Europe Market Attractiveness by Country, 2022-2032
Figure 81: South Asia Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 82: South Asia Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 83: South Asia Market Value (US$ Mn) by End-use , 2022-2032
Figure 84: South Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 85: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: South Asia Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 89: South Asia Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 91: South Asia Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 92: South Asia Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 94: South Asia Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 97: South Asia Market Attractiveness by Procedure Type, 2022-2032
Figure 98: South Asia Market Attractiveness by Cellulite Type, 2022-2032
Figure 99: South Asia Market Attractiveness by End-use , 2022-2032
Figure 100: South Asia Market Attractiveness by Country, 2022-2032
Figure 101: East Asia Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 102: East Asia Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 103: East Asia Market Value (US$ Mn) by End-use , 2022-2032
Figure 104: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 105: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: East Asia Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 109: East Asia Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 111: East Asia Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 112: East Asia Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 114: East Asia Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 117: East Asia Market Attractiveness by Procedure Type, 2022-2032
Figure 118: East Asia Market Attractiveness by Cellulite Type, 2022-2032
Figure 119: East Asia Market Attractiveness by End-use , 2022-2032
Figure 120: East Asia Market Attractiveness by Country, 2022-2032
Figure 121: Oceania Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 122: Oceania Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 123: Oceania Market Value (US$ Mn) by End-use , 2022-2032
Figure 124: Oceania Market Value (US$ Mn) by Country, 2022-2032
Figure 125: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: Oceania Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 131: Oceania Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 134: Oceania Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 137: Oceania Market Attractiveness by Procedure Type, 2022-2032
Figure 138: Oceania Market Attractiveness by Cellulite Type, 2022-2032
Figure 139: Oceania Market Attractiveness by End-use , 2022-2032
Figure 140: Oceania Market Attractiveness by Country, 2022-2032
Figure 141: MEA Market Value (US$ Mn) by Procedure Type, 2022-2032
Figure 142: MEA Market Value (US$ Mn) by Cellulite Type, 2022-2032
Figure 143: MEA Market Value (US$ Mn) by End-use , 2022-2032
Figure 144: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 145: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 148: MEA Market Value (US$ Mn) Analysis by Procedure Type, 2017-2032
Figure 149: MEA Market Value Share (%) and BPS Analysis by Procedure Type, 2022-2032
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Procedure Type, 2022-2032
Figure 151: MEA Market Value (US$ Mn) Analysis by Cellulite Type, 2017-2032
Figure 152: MEA Market Value Share (%) and BPS Analysis by Cellulite Type, 2022-2032
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Cellulite Type, 2022-2032
Figure 154: MEA Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 155: MEA Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 157: MEA Market Attractiveness by Procedure Type, 2022-2032
Figure 158: MEA Market Attractiveness by Cellulite Type, 2022-2032
Figure 159: MEA Market Attractiveness by End-use , 2022-2032
Figure 160: MEA Market Attractiveness by Country, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what value is the cellulite treatment industry likely to close by 2022?
Fact.MR foresees cellulite treatment demand to reach US$ 1.46 Billion in 2022.
At what percentage will the market for cellulite treatment rise until 2032?
From 2022-2032, Fact.MR expects cellulite treatment revenue to flourish at a 12% CAGR.
What is the expected market value for cellulite treatment in 2032?
In 2032, cellulite treatment market worth is poised to reach US$ 4.52 Billion.
How do growth prospects for cellulite treatment appear in North America?
The North American regional market is expected to hold a share of 38%.
Which type of cellulite is expected to hold the maximum share for the cellulite treatment market?
The soft cellulite segment held the largest revenue share of over 45.0%. This can be attributed to the high prevalence of obesity owing to unhealthy diet and lifestyle habits.
Which type of end-user is expected to hold the maximum share for the cellulite treatment market?
The clinics and beauty centers segment held the largest revenue share of over 60.0%. Cellulite formation is a common problem observed in women aged 20 and above.
What was the market worth for cellulite treatment in 2021?
As of 2021, the cellulite treatment market was worth US$ 1.30 Billion.
Cellulite Treatment Market